Jane J. Zara

Array ( [id] => 4563945 [patent_doc_number] => 07846730 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Antisense modulation of BCL2-associated X protein expression' [patent_app_type] => utility [patent_app_number] => 10/728509 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27853 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846730.pdf [firstpage_image] =>[orig_patent_app_number] => 10728509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 311093 [patent_doc_number] => 07528117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'High efficacy antisense RIαPKA poly-DNP oligoribonucleotides' [patent_app_type] => utility [patent_app_number] => 10/728491 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 9602 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528117.pdf [firstpage_image] =>[orig_patent_app_number] => 10728491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7149670 [patent_doc_number] => 20040171044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Delivery of substances to cells' [patent_app_type] => new [patent_app_number] => 10/727109 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7289 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171044.pdf [firstpage_image] =>[orig_patent_app_number] => 10727109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7185148 [patent_doc_number] => 20050191732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation' [patent_app_type] => utility [patent_app_number] => 10/721922 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50443 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191732.pdf [firstpage_image] =>[orig_patent_app_number] => 10721922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851775 [patent_doc_number] => 20060234966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Method for expressing inducible rna [in cells, nucleic acid molecules therefor and cells transformed by said molecules' [patent_app_type] => utility [patent_app_number] => 10/535692 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2906 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234966.pdf [firstpage_image] =>[orig_patent_app_number] => 10535692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 485293 [patent_doc_number] => 07217572 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-15 [patent_title] => 'Modulation of HIF1α and HIF2α expression' [patent_app_type] => utility [patent_app_number] => 10/719370 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34842 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/217/07217572.pdf [firstpage_image] =>[orig_patent_app_number] => 10719370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034216 [patent_doc_number] => 20050032726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Uses of DNA-PK' [patent_app_type] => utility [patent_app_number] => 10/712642 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 25607 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032726.pdf [firstpage_image] =>[orig_patent_app_number] => 10712642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169122 [patent_doc_number] => 20040077580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Antisense modulation of PI3K P85 Expression' [patent_app_type] => new [patent_app_number] => 10/703864 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24545 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077580.pdf [firstpage_image] =>[orig_patent_app_number] => 10703864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288075 [patent_doc_number] => 20040147470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Cross-linked oligomeric compounds and their use in gene modulation' [patent_app_type] => new [patent_app_number] => 10/701012 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33712 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147470.pdf [firstpage_image] =>[orig_patent_app_number] => 10701012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239392 [patent_doc_number] => 08604183 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Compositions comprising alternating 2′-modified nucleosides for use in gene modulation' [patent_app_type] => utility [patent_app_number] => 10/701007 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47867 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10701007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7446484 [patent_doc_number] => 20040067259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Supercritical fluid-assisted nebulization and bubble drying' [patent_app_type] => new [patent_app_number] => 10/681061 [patent_app_country] => US [patent_app_date] => 2003-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 13656 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067259.pdf [firstpage_image] =>[orig_patent_app_number] => 10681061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7411142 [patent_doc_number] => 20040106571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Gene BRCC-3 and diagnostic and therapeutic uses thereof' [patent_app_type] => new [patent_app_number] => 10/679561 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13826 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106571.pdf [firstpage_image] =>[orig_patent_app_number] => 10679561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5820483 [patent_doc_number] => 20060024796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Transcriptional activator gene for genes involved in cobalamin biosynthesis' [patent_app_type] => utility [patent_app_number] => 10/528674 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8093 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024796.pdf [firstpage_image] =>[orig_patent_app_number] => 10528674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 508227 [patent_doc_number] => 07198949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-03 [patent_title] => 'Compositions and methods for altering the biodistribution of biological agents' [patent_app_type] => utility [patent_app_number] => 10/668448 [patent_app_country] => US [patent_app_date] => 2003-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9867 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/198/07198949.pdf [firstpage_image] =>[orig_patent_app_number] => 10668448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7211004 [patent_doc_number] => 20050053951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Riboswitches, methods for their use, and compositions for use with riboswitches' [patent_app_type] => utility [patent_app_number] => 10/669162 [patent_app_country] => US [patent_app_date] => 2003-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 89 [patent_figures_cnt] => 89 [patent_no_of_words] => 66757 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053951.pdf [firstpage_image] =>[orig_patent_app_number] => 10669162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7323587 [patent_doc_number] => 20040137471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Efficient reduction of target RNA\'s by single-and double-stranded oligomeric compounds' [patent_app_type] => new [patent_app_number] => 10/664639 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21327 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137471.pdf [firstpage_image] =>[orig_patent_app_number] => 10664639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7324039 [patent_doc_number] => 20040137623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Delivery of oligonucleotide compounds into osteoclasts and modulation of osteoclast differentiation' [patent_app_type] => new [patent_app_number] => 10/666909 [patent_app_country] => US [patent_app_date] => 2003-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28027 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137623.pdf [firstpage_image] =>[orig_patent_app_number] => 10666909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 415382 [patent_doc_number] => 07279566 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-09 [patent_title] => 'Centrosome proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/663433 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 96 [patent_no_of_words] => 26027 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/279/07279566.pdf [firstpage_image] =>[orig_patent_app_number] => 10663433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432309 [patent_doc_number] => 20040162254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Antiviral oligonucleotides targeting HSV and CMV' [patent_app_type] => new [patent_app_number] => 10/661097 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 35259 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162254.pdf [firstpage_image] =>[orig_patent_app_number] => 10661097 [rel_patent_id] =>[rel_patent_doc_number] =>)